BMC Cancer, in partnership with Research Square has launched In Review, a new option that provides authors with on-demand information on the status of their manuscript, enables them to share their work with funders and their research community, and allows their colleagues to comment and collaborate - all whilst their manuscript is under review.
In Review
See your BMC Cancer manuscript’s review progress with our first-of-its-kind In Review service
Authors choosing this free optional service will be able to:
- Share their work with fellow researchers to read, comment on, and cite even before publication
- Showcase their work to funders and others with a citable DOI while it is still under review
- Track their manuscript - including seeing when reviewers are invited, and when reports are received
Annual Journal Metrics
-
2022 Citation Impact
3.8 - 2-year Impact Factor
4.3 - 5-year Impact Factor
1.166 - SNIP (Source Normalized Impact per Paper)
1.137 - SJR (SCImago Journal Rank)2023 Speed
30 days submission to first editorial decision for all manuscripts (Median)
150 days submission to accept (Median)2023 Usage
7,974,312 downloads
3,975 Altmetric mentions
Peer-review Terminology
-
The following summary describes the peer review process for this journal:
Identity transparency: Single anonymized
Reviewer interacts with: Editor
Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication